<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7236853\results\search\disease\results.xml">
  <result pre="Influence of inhibitors of the reninâ€&quot;angiotensin system on risk of" exact="acute" post="respiratory distress syndrome in Danish hospitalized COVID-19 patients HoltAndersMizrakIkramLambertsMortenLav"/>
  <result pre="of inhibitors of the reninâ€&quot;angiotensin system on risk of acute" exact="respiratory" post="distress syndrome in Danish hospitalized COVID-19 patients HoltAndersMizrakIkramLambertsMortenLav MadsenPer[],"/>
  <result pre="of the reninâ€&quot;angiotensin system on risk of acute respiratory distress" exact="syndrome" post="in Danish hospitalized COVID-19 patients HoltAndersMizrakIkramLambertsMortenLav MadsenPer[], Correspondence to"/>
  <result pre="and Europe PMC, consistent with existing copyright protections.jhype-publish-ahead-of-print-10.1097.hjh.0000000000002515.pdf COVID-19, the" exact="disease" post="associated with SARS-CoV-2 infection, is in some 20% of"/>
  <result pre="is in some 20% of acutely affected patients associated with" exact="respiratory" post="distress syndrome (ARDS) often necessitating respirator treatment and associated"/>
  <result pre="some 20% of acutely affected patients associated with respiratory distress" exact="syndrome" post="(ARDS) often necessitating respirator treatment and associated with a"/>
  <result pre="from a high level of angiotensin II (Ang-II) via the" exact="type 1" post="receptor pathway [4], and Ang-II has already been demonstrated"/>
  <result pre="the reninâ€&quot;angiotensin system (RASi), cornerstones of treatment of patients with" exact="hypertension" post="and heart failure, have attracted attention as they may"/>
  <result pre="reninâ€&quot;angiotensin system (RASi), cornerstones of treatment of patients with hypertension" exact="and heart" post="failure, have attracted attention as they may in theory"/>
  <result pre="system (RASi), cornerstones of treatment of patients with hypertension and" exact="heart" post="failure, have attracted attention as they may in theory"/>
  <result pre="level of Ang-II, but SARS-CoV-2 virus binds to ACE2 receptors," exact="lower" post="their activity and hence increase Ang-II activity [1]. While"/>
  <result pre="their activity and hence increase Ang-II activity [1]. While RASi" exact="lower" post="Ang-II levels, and may in this respect be helpful,"/>
  <result pre="lower Ang-II levels, and may in this respect be helpful," exact="chronic" post="RASi treatment may on the other hand also increase"/>
  <result pre="chronic RASi treatment may on the other hand also increase" exact="pulmonary" post="ACE2-receptor numbers hence providing a possible higher SARS-CoV-2 viral"/>
  <result pre="increase pulmonary ACE2-receptor numbers hence providing a possible higher SARS-CoV-2" exact="viral" post="load. As suggested from animal experiments, chronic treatment with"/>
  <result pre="possible higher SARS-CoV-2 viral load. As suggested from animal experiments," exact="chronic" post="treatment with RASi can therefore, in theory, both increase"/>
  <result pre="treatment with RASi can therefore, in theory, both increase and" exact="lower" post="the risk of ARDS in SARS-CoV-2-infected patients. Studies early"/>
  <result pre="the risk of ARDS in SARS-CoV-2-infected patients. Studies early listed" exact="heart" post="disease, hypertension, and diabetes as risk factors for ARDS"/>
  <result pre="in SARS-CoV-2-infected patients. Studies early listed heart disease, hypertension, and" exact="diabetes" post="as risk factors for ARDS [1â€&quot;3], but unfortunately medication"/>
  <result pre="1 March and 1 April 2020, had remained admitted with" exact="infection" post="to hospital for at least 24â€Šh in two of"/>
  <result pre="adjusted for time to event or censoring. Out of a" exact="total" post="of 2700 PCR positive patients, 689 patients (25.5%) were"/>
  <result pre="2.04 further days (SD 2.29; range 0â€&quot;10). Medical treatment for" exact="chronic" post="obstructive pulmonary disease, statins, antithrombotic drugs, and RASi were"/>
  <result pre="days (SD 2.29; range 0â€&quot;10). Medical treatment for chronic obstructive" exact="pulmonary" post="disease, statins, antithrombotic drugs, and RASi were equally prevalent"/>
  <result pre="treatment in patients with SARS-CoV-2 infection. Whereas we found other" exact="heart" post="failure medication to be of importance, probably mainly reflecting"/>
  <result pre="comorbidity, our data do not suggest any significant influence from" exact="chronic" post="RASi treatment and hence our data bring some reassurance"/>
  <result pre="consider timing the intervention early in the course of the" exact="disease" post="or well before infection, since if patients do develop"/>
  <result pre="patients do develop ARDS they do so after a very" exact="short" post="time period. ACKNOWLEDGEMENTS Conflicts of interest There are no"/>
  <result pre="323:1574â€&quot;1581. 2ZhouFYuTDuRFanGLiuYXiangJet al.Clinical course and risk factors for mortality of" exact="adult" post="inpatients with COVID-19 in Wuhan, China: a retrospective cohort"/>
  <result pre="al.Clinical and biochemical indexes from 2019-nCOV infected patients linked to" exact="viral" post="loads and lung injury. Sci China Life Sci2020; 63:364â€&quot;374.32048163"/>
 </snippets>
</snippetsTree>
